跳至主要内容
临床试验/ACTRN12622001330730
ACTRN12622001330730招募中1 期

Elucidating the effects of nebulized sodium nitrite and argon on blood pressure and cerebrovascular haemodynamics in healthy adults and hypertensive patients

niversity of Auckland0 个研究点目标入组 80 人开始时间: 2022年10月14日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Patients with essential hypertension (At least Stage 2 hypertension; untreated office systolic blood pressure (SBP) greater than or equal to 140 mmHg or diastolic blood pressure (DBP_ greater than or equal to 90 mmHg);
  • Patients with chronic atrial fibrillation, as established on ECG or Holter monitoring
  • Normotensive controls (office SBP less than or equal to 120 mmHg and DBP less than or equal to 80 mmHg);
  • Aged over 18 years;
  • Body mass index less than 35 kg/m2.

排除标准

  • Hemodynamically significant valvular heart disease (excluding atrial fibrillation e.g., stenosis, mechanical valve replacement)
  • Severe left ventricular systolic dysfunction
  • Recent acute coronary syndrome (<12 months) (e.g., myocardiac infarction, angioplasty, unstable angina)
  • Previous coronary artery bypass surgery
  • Secondary causes of hypertension (e.g., phaeochromocytoma)
  • Recent stroke/transient ischaemic attack (<12 months)
  • Current smoker
  • Body mass index <18 kg/m2.
  • Current pregnancy
  • Current user of recreational drugs
  • Current abuser of alcohol
  • Inability to fully or appropriately provide consent (e.g., language issue, reading capability)
  • Underlying medical conditions, which in the opinion of the Investigator place the participant at unacceptably high risk for participating in the study.
  • Chronic and systemic illness including:
  • Severe respiratory disease (e.g., chronic obstructive pulmonary disease);
  • Severe, uncontrolled type II diabetes;
  • Current treatment for cancer or complete remission <5 years
  • Connective tissue or inflammatory disease
  • Neurological / psychiatric disease (e.g., peripheral neuropathy, dementia, Parkisnon’s, epilepsy)
  • Infection or pyrexial illness
  • Uncontrolled thyroid disorders
  • Renal impairment (e.g., glomerulus filtration rate less than 60)
  • Liver disease

研究者

发起方
niversity of Auckland

相似试验